tiprankstipranks
Trending News
More News >
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market

Oncolytics Biotech (ONCY) Financial Statements

Compare
1,413 Followers

Oncolytics Biotech Financial Overview

Oncolytics Biotech's market cap is currently $104.13M. The company's EPS TTM is $-0.1; its P/E ratio is -3.53; Oncolytics Biotech is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ -298.59KC$ -301.11KC$ -360.57KC$ -332.65K
Operating IncomeC$ -34.98MC$ -25.04MC$ -20.68MC$ -20.93MC$ -18.98M
EBITDAC$ -34.88MC$ -20.19MC$ -18.71MC$ -20.58MC$ -16.45M
Net IncomeC$ -31.71MC$ -20.56MC$ -19.08MC$ -20.98MC$ -16.78M
Balance Sheet
Cash & Short-Term InvestmentsC$ 15.94MC$ 34.91MC$ 32.14MC$ 41.26MC$ 31.22M
Total AssetsC$ 20.19MC$ 38.82MC$ 37.33MC$ 45.88MC$ 34.35M
Total DebtC$ 1.06MC$ 423.00KC$ 373.00KC$ 655.00KC$ 402.06K
Net DebtC$ -14.88MC$ -34.49MC$ -11.29MC$ -40.61MC$ -30.82M
Total LiabilitiesC$ 14.20MC$ 11.26MC$ 10.83MC$ 9.78MC$ 9.59M
Stockholders' EquityC$ 5.98MC$ 27.56MC$ 26.50MC$ 36.10MC$ 24.75M
Cash Flow
Free Cash FlowC$ -27.20MC$ -28.46MC$ -23.41MC$ -22.72MC$ -22.10M
Operating Cash FlowC$ -26.97MC$ -28.45MC$ -23.36MC$ -22.43MC$ -22.07M
Investing Cash FlowC$ -239.00KC$ 20.22MC$ -20.40MC$ -285.95KC$ -29.30K
Financing Cash FlowC$ 6.64MC$ 31.99MC$ 12.21MC$ 33.02MC$ 39.77M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Oncolytics Biotech Debt to Assets

Oncolytics Biotech Cash Flow

Oncolytics Biotech Forecast EPS vs Actual EPS